Exclusion criteria
malignancy, abnormal liver function, hypersensitivity, renal impairment
RENAL IMPAIRMENT, ISCHEMIC HEART DISEASE, TYPE 1 DIABETES, BLADDER CANCER, HEART FAILURE, HYPERSENSITIVITY
Patients excluded from the study were those with type 1 diabetes, hepatic impairment, malignancy, heart failure, history of ischemic heart disease, planned surgical intervention, and both pregnant and nursing women, hypersensitivity to the study drugs, abnormal liver function, renal impairment (eGFR ≤ 60 ml/min) or history of bladder cancer.